MarketPulse

animal health

5 articles
BenzingaBenzinga··Vandana Singh

Elanco Surges 9% on Strong Q1 Earnings Beat, Raised Guidance

Elanco Animal Health ($ELAN) stock jumped 9.33% after Q1 earnings beat and raised full-year guidance, driven by Pet Health and Farm Animal segment growth.
ELANearningsrevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Veterinary Clinical Trial Standards Tighten: New GCP Training Addresses Global Regulatory Compliance

ResearchAndMarkets launches May 2026 VICH GCP training for veterinary clinical trials, addressing regulatory harmonization and compliance requirements across EU and USA markets.
CRLregulatory compliancedata quality
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Healthcare Giants $JNJ and $ZTS Emerge as Top Dividend Plays for 2026

Johnson & Johnson and Zoetis identified as premier dividend stocks for income investors, citing consistent growth, innovation pipelines, and demographic tailwinds.
JNJZTShealthcaredividend stocks
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Mangoceuticals Files Global Patent for MGX-0024 Avian Antiviral as H5N1 Protection Expands

Mangoceuticals files PCT patent application for MGX-0024 antiviral additive, following clinical trials showing zero mortality in 29,000 birds against H5N1 avian influenza.
MGRXintellectual propertyglobal expansion
The Motley FoolThe Motley Fool··Adé Hennis

Phibro CEO Divests $3.74M in Stock Following Robust Second-Quarter Results

Phibro CEO Jack Bendheim sold $3.74M in stock via pre-planned trading agreement following strong Q2 results driven by expanded product portfolio and strategic acquisitions.
PAHCearnings growthinsider trading